Munafa Stock Market Course + Intraday & FNO calls 
Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biomarin Pharmaceutical (BMRN)
Technical Analysis Report for USA stock BMRN Biomarin Pharmaceutical. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical then click here. or read Experts views on Biomarin Pharmaceutical or Forecast & share price targets of Biomarin Pharmaceutical
Biomarin Pharmaceutical Opened at 60.71 and Closed at: 59.74, which is -3.33% of previous session's close. It moved within a range of 59.25 and 61.14
The session was a Bearish session with an average volume of 1953200, which is -11.61% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
Support for tomorrow is 58.55 and resistance for tomorrow is 60.44
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 58.95, 58.15 resistance for tomorrow's hourly charts is 60.84, 61.93
10 Day SMA for Biomarin Pharmaceutical (BMRN) is 61.88 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Biomarin Pharmaceutical (BMRN) is 60.34 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Biomarin Pharmaceutical (BMRN) is 58.9 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 56.22 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Biomarin Pharmaceutical is 56.59 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Biomarin Pharmaceutical is at 60.34 and 200 DMA is at 56.59, while 50 DMA and 100 DMA are at 58.9 and 56.22 respectively
Biomarin Pharmaceutical (BMRN) moving average of 20 SMA is at 60.34 and 20 EMA is at 60.48
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Mon Mar | 59.74 | 60.34 | 60.48 |
| 27 Fri Feb | 61.73 | 60.25 | 60.56 |
| 26 Thu Feb | 61.11 | 59.99 | 60.44 |
| 25 Wed Feb | 61.44 | 59.79 | 60.37 |
| 24 Tue Feb | 62.62 | 59.55 | 60.26 |
| 23 Mon Feb | 62.92 | 59.26 | 60.01 |
Biomarin Pharmaceutical (BMRN) moving average of 50 SMA is at 58.9 and 50 EMA is at 58.77
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Mon Mar | 59.74 | 58.9 | 58.77 |
| 27 Fri Feb | 61.73 | 58.74 | 58.73 |
| 26 Thu Feb | 61.11 | 58.54 | 58.61 |
| 25 Wed Feb | 61.44 | 58.36 | 58.51 |
| 24 Tue Feb | 62.62 | 58.2 | 58.39 |
| 23 Mon Feb | 62.92 | 58 | 58.22 |
Biomarin Pharmaceutical (BMRN) moving average of 100 SMA is at 56.22 and 100 EMA is at 57.69
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Mon Mar | 59.74 | 56.22 | 57.69 |
| 27 Fri Feb | 61.73 | 56.17 | 57.65 |
| 26 Thu Feb | 61.11 | 56.1 | 57.57 |
| 25 Wed Feb | 61.44 | 56.05 | 57.5 |
| 24 Tue Feb | 62.62 | 55.99 | 57.42 |
| 23 Mon Feb | 62.92 | 55.92 | 57.31 |
Biomarin Pharmaceutical (BMRN) moving average of 200 SMA is at 56.59 and 200 EMA is at 58.71
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Mon Mar | 59.74 | 56.59 | 58.71 |
| 27 Fri Feb | 61.73 | 56.59 | 58.7 |
| 26 Thu Feb | 61.11 | 56.59 | 58.67 |
| 25 Wed Feb | 61.44 | 56.58 | 58.65 |
| 24 Tue Feb | 62.62 | 56.57 | 58.62 |
| 23 Mon Feb | 62.92 | 56.55 | 58.58 |
Takeda Pharmaceutical has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 2.09% more returns!
Biomarin Pharmaceutical has performed better than Penumbra Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Medtronic Plc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Johnson Johnson has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Johnson Johnson, about 2.93% more returns!
Biomarin Pharmaceutical has performed better than Iqvia Holdings in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Glaxosmithkline Plc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 5.52% more returns!
Encompass Health has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Encompass Health, about 10.82% more returns!
Staar Surgical has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Staar Surgical, about 1.26% more returns!
Biomarin Pharmaceutical has performed better than Opko Health in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Natera Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Masimo Corporation has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Masimo Corporation, about 22.37% more returns!
Kamada has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Kamada, about 7.18% more returns!
Biomarin Pharmaceutical has performed better than Iterum Therapeutics in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Insmed Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Incyte Corporation in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Henry Schein has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Henry Schein, about 7.55% more returns!
Biomarin Pharmaceutical has performed better than Fonar Corporation in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Axogen Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical Technical analysis of indicators
Price action analysis of Biomarin Pharmaceutical (BMRN) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term but the sell signal is initial and weak.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biomarin Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 62.29 and Biomarin Pharmaceutical BMRN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical BMRN stock. Volume based technical analysis of Biomarin Pharmaceutical BMRN stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BMRN Experts View which covers a lot of information including buying and selling signals
BMRN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biomarin Pharmaceutical or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
